Fabrinet Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Fabrinet (incorporated in the Cayman Islands) on February 8, 2015. The report discloses amendments to employment agreements for two senior executives of Fabrinet USA, Inc. (FUSA), a wholly-owned subsidiary of Fabrinet.
Key Financial Metrics
The filing does not provide specific financial metrics such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on executive compensation arrangements.
Material Changes
On February 8, 2015, the following material changes to executive compensation occurred:
- Harpal Gill: President and Chief Operating Officer of FUSA entered into an amended and restated offer letter.
- Toh-Seng Ng: Executive Vice President and Chief Financial Officer of FUSA entered into an amended and restated offer letter.
Guidance, Outlook, and Management Commentary
The filing details specific severance and retirement benefits triggered by termination without "good cause" or for "good reason" prior to specific transition dates:
- Severance Package: Both executives are eligible for a lump sum equal to 12 months of base salary plus any earned but unpaid bonus.
- Health Benefits: Eligibility for a lump sum equal to two times the cost of COBRA coverage for 12 months.
- Equity Vesting: Immediate 100% vesting of all outstanding equity-based awards (options, restricted stock, RSUs, etc.) upon qualifying termination.
- Tax Benefits: Continued tax equalization benefits under the expatriate policy for the termination year and the following calendar year.
- Retention Benefits: Specific "Retention Benefits" apply if employment terminates on or within 10 days of the "Transition Date" (May 7, 2018 for Dr. Gill; December 30, 2018 for Mr. Ng). These include a lump sum calculated as one month's base salary multiplied by total years of employment, plus the benefits listed above.
- Death or Disability: Immediate 100% vesting of equity awards applies if termination is due to death or disability prior to the Transition Date.
Investor Verification Checklist
- Verify the exact terms of "good cause" and "good reason" as defined in the attached Exhibit 10.1 and Exhibit 10.2.
- Confirm the current base salary figures for Dr. Gill and Mr. Ng to estimate potential severance liabilities.
- Review the outstanding equity awards held by these executives to assess the potential dilution impact of immediate vesting.
- Check subsequent filings for any actual terminations or further amendments to these agreements.